We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1B
AUM Growth
-$53.8M
Cap. Flow
-$76.8M
Cap. Flow %
-7.64%
Top 10 Hldgs %
59.4%
Holding
205
New
27
Increased
43
Reduced
99
Closed
23

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.91%
2 Financials 5.49%
3 Healthcare 2.31%
4 Technology 2.14%
5 Industrials 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
51
CVS Health
CVS
$124B
$2.97M 0.3%
33,423
-2,186
-6% -$206K
XOM icon
52
ExxonMobil
XOM
$656B
$2.75M 0.27%
31,551
+2,068
+7% +$183K
USMV icon
53
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
$2.73M 0.27%
60,042
-7,482
-11% -$346K
BBH icon
54
VanEck Biotech ETF
BBH
$479M
$2.71M 0.27%
23,565
-1,016
-4% -$116K
WFC icon
55
Wells Fargo
WFC
$272B
$2.69M 0.27%
60,657
+7,610
+14% +$364K
DHR icon
56
Danaher
DHR
$146B
$2.6M 0.26%
37,461
-16,336
-30% -$1.16M
AMJ
57
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$2.56M 0.25%
81,142
-76,548
-49% -$2.41M
INTC icon
58
Intel
INTC
$506B
$2.5M 0.25%
66,102
-48,381
-42% -$1.71M
HD icon
59
Home Depot
HD
$320B
$2.42M 0.24%
18,776
-2,525
-12% -$336K
VAW icon
60
Vanguard Materials ETF
VAW
$3.07B
$2.42M 0.24%
22,595
-11,812
-34% -$1.27M
IWN icon
61
iShares Russell 2000 Value ETF
IWN
$14.6B
$2.41M 0.24%
22,991
-3,157
-12% -$324K
SCHW
62
Charles Schwab
SCHW
$189B
$2.4M 0.24%
76,120
-27,537
-27% -$807K
VYM icon
63
Vanguard High Dividend Yield ETF
VYM
$82.8B
$2.36M 0.24%
32,739
+25,119
+330% +$1.82M
BND icon
64
Vanguard Total Bond Market
BND
$160B
$2.33M 0.23%
27,747
+11,370
+69% +$957K
VCR icon
65
Vanguard Consumer Discretionary ETF
VCR
$5.94B
$2.32M 0.23%
18,420
-6,167
-25% -$779K
SE
66
DELISTED
Spectra Energy Corp Wi
SE
$2.21M 0.22%
51,740
-49,927
-49% -$1.9M
VV icon
67
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$2.15M 0.21%
21,720
+14,995
+223% +$1.49M
ABT icon
68
Abbott
ABT
$187B
$2.14M 0.21%
50,620
-1,513
-3% -$64.8K
AGN
69
DELISTED
Allergan plc
AGN
$2.02M 0.2%
+8,766
New +$2.14M
MSFT icon
70
Microsoft
MSFT
$3.71T
$2.01M 0.2%
34,830
-6,326
-15% -$357K
HEDJ icon
71
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$1.98M 0.2%
73,730
-384,314
-84% -$10.2M
T icon
72
AT&T
T
$176B
$1.98M 0.2%
64,460
+7,993
+14% +$253K
VTI icon
73
Vanguard Morningstar Total Stock Market ETF
VTI
$688B
$1.91M 0.19%
17,144
+191
+1% +$21.2K
SLB icon
74
SLB Ltd
SLB
$85.3B
$1.82M 0.18%
23,192
-930
-4% -$73.8K
EOG icon
75
EOG Resources
EOG
$76.2B
$1.8M 0.18%
18,632
-612
-3% -$53.7K

Similar funds

Aspiriant LLC's Q3 2016 Portfolio in Review

As of Q3 2016, Aspiriant LLC held 205 positions worth $1B, down 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Aspiriant LLC withdrew a net $76.8M in Q3 2016, closing 23 positions and reducing 99 holdings. Its most notable exit was Xtrackers MSCI All World ex US Hedged Equity ETF, an estimated $9.69M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, down from 83% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Aspiriant LLC opened a new position in State Street Real Estate Select Sector SPDR ETF worth $3.4M.

  • Aspiriant LLC's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 103,791 shares worth $3.4M.
  • Aspiriant LLC added most to Vanguard FTSE Developed Markets ETF in Q3 2016, an estimated $22.7M increase.
  • Aspiriant LLC's biggest Q3 2016 reduction was State Street SPDR Dow Jones International Real Estate ETF, cutting an estimated $17.3M.
  • Aspiriant LLC fully exited Xtrackers MSCI All World ex US Hedged Equity ETF in Q3 2016, selling an estimated $9.69M.
  • Aspiriant LLC's ten largest holdings make up 59% of its $1B portfolio in Q3 2016.
  • Aspiriant LLC opened 27 new positions and closed 23 in Q3 2016.
  • Aspiriant LLC's portfolio value fell 5.1% quarter-over-quarter to $1B.

Based on Aspiriant LLC's 13F filing for Q3 2016, filed 10 Nov 2016.